Testing effectiveness (Phase 2)Study completedNCT01842321What this trial is testingAbiraterone Acetate in Molecular Apocrine Breast CancerWho this might be right forBreast Cancer UNICANCER 34
Testing effectiveness (Phase 2)Study completedNCT02218606What this trial is testingMulticenter Trial of Abiraterone Acetate With or Without Cabazitaxel in Treatment of Metastatic Castration Resistant Prostate CancerWho this might be right forProstate Cancer Memorial Sloan Kettering Cancer Center 81
Testing effectiveness (Phase 2)Study completedNCT01199146What this trial is testingAbiraterone Post Ketoconazole for Prostate CancerWho this might be right forProstate Cancer University of California, San Francisco 42
Testing effectiveness (Phase 2)Study completedNCT01485861What this trial is testingStudy of Ipatasertib or Apitolisib With Abiraterone Acetate Versus Abiraterone Acetate in Participants With Castration-Resistant Prostate Cancer Previously Treated With Docetaxel ChemotherapyWho this might be right forProstate Cancer Genentech, Inc. 298
Not applicableStudy completedNCT05520138What this trial is testingEnzalutamide vs. Abiraterone in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC)Who this might be right forProstatic Neoplasms, Castration-Resistant Pfizer 5,506
Not applicableStudy completedNCT05968599What this trial is testingLearn About the Study Medicines Called Enzalutamide and Abiraterone in People With Metastatic Castration-resistant Prostate CancerWho this might be right forProstatic Neoplasms, Castration-Resistant Pfizer 2,731
Early research (Phase 1)Study completedNCT01884285What this trial is testingAZD8186 First Time In Patient Ascending Dose StudyWho this might be right forAdvanced Castrate-resistant Prostate Cancer CRPCSquamous Non-Small Cell Lung Cancer sqNSCLCTriple Negative Breast Cancer TNBC AstraZeneca 147
Very early researchUnknownNCT04735913What this trial is testingEffects of Metabolic Enzymes and Transporter Gene Polymorphisms on the Pharmacokinetics and Metabolism of Oral Abiraterone Acetate in Healthy Chinese AdultsWho this might be right forAbiraterone AcetateGene PolymorphismPharmacokinetic+2 more Zhongnan Hospital 81
Testing effectiveness (Phase 2)Study completedNCT00474383What this trial is testingAn Safety and Efficacy Study of Abiraterone Acetate in Participants With Advanced Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based ChemotherapyWho this might be right forProstate Neoplasms Cougar Biotechnology, Inc. 47
Early research (Phase 1)Study completedNCT01792687What this trial is testingSafety, Tolerability, Pharmacokinetics, and Preliminary Anti-tumor Activity of Ascending Doses of ARN 509 in Combination With Abiraterone AcetateWho this might be right forProstate Cancer Aragon Pharmaceuticals, Inc. 6
Testing effectiveness (Phase 2)Study completedNCT01940276What this trial is testingAbiraterone Race in Metastatic Castrate-resistant Prostate CancerWho this might be right forProstate Cancer Duke University 100
Early research (Phase 1)Study completedNCT01495910What this trial is testingA Study Examining Doses of Abiraterone Acetate in Adult Women With 21-Hydroxylase DeficiencyWho this might be right for21-hydroxylase Deficiency Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 6
Testing effectiveness (Phase 2)Study completedNCT02025010What this trial is testingStudy of Abiraterone Acetate Without Exogenous Glucocorticoids in Men With Castration-resistant Prostate CancerWho this might be right forCastration-resistant Prostate Cancer Dana-Farber Cancer Institute 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT04267887What this trial is testingAdvanced ChemoHormonal Therapy for Treatment Naive Metastatic Prostate CancerWho this might be right forCastration-Sensitive Prostate CarcinomaMetastatic Prostate CarcinomaStage IVB Prostate Cancer AJCC v8 OHSU Knight Cancer Institute 7
Large-scale testing (Phase 3)Study completedNCT03834519What this trial is testingStudy of Pembrolizumab (MK-3475) Plus Olaparib Versus Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-7339-010/KEYLYNK-010)Who this might be right forProstatic Neoplasms Merck Sharp & Dohme LLC 793
Testing effectiveness (Phase 2)Study completedNCT01685268What this trial is testingHSP90 Inhibitor AT13387 Alone or in Combination With Abiraterone AcetateWho this might be right forProstate Cancer Astex Pharmaceuticals, Inc. 49
Early research (Phase 1)Study completedNCT01400555What this trial is testingA Safety Study of Abiraterone Acetate Administered in Combination With Docetaxel in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)Who this might be right forProstate NeoplasmsProstate Cancer Cougar Biotechnology, Inc. 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT02949284What this trial is testingAndrogen Receptor Antagonist ARN-509 With or Without Abiraterone Acetate, Gonadotropin-Releasing Hormone Analog, and Prednisone in Treating Patients With High-Risk Prostate Cancer Undergoing SurgeryWho this might be right forStage II Prostate AdenocarcinomaStage III Prostate Adenocarcinoma Rutgers, The State University of New Jersey 90
Early research (Phase 1)Active Not RecruitingNCT02123758What this trial is testingJNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate CancerWho this might be right forProstatic NeoplasmsMetastatic Castration-Resistant Prostate Cancer Aragon Pharmaceuticals, Inc. 57
Testing effectiveness (Phase 2)UnknownNCT03145285What this trial is testingActivity of Abiraterone Acetate in the Management of Cushing's Syndrome in Patients With Adrenocortical CarcinomaWho this might be right forCushing SyndromeAdrenocortical Carcinoma Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 10